Company intelligence / Profile preview

Novomic

Hunan, China
Ownership
Private
Development stage
Other
01

Overview

Hunan Novomic Biological Technology focuses on developing, producing, and selling health and cosmetic products for the Greater China market.[3]

Therapeutic areas
OtherDermatology
Modalities
Non-pharmacological therapyDevice
Industry
Non-Drug Biotech
02

Partnerships

China-Israel Biological Technology (CIBT)[3]TechCare (via joint venture with CIBT)[3]

Beyond the preview

Go deeper on Novomic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novomic.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call